Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Sarah E. Paraghamian"'
Autor:
Jianqing Qiu, Ziyi Zhao, Hongyan Suo, Sarah E. Paraghamian, Gabrielle M. Hawkins, Wenchuan Sun, Xin Zhang, Tianran Hao, Beor Deng, Xiaochang Shen, Chunxiao Zhou, Victoria Bae-Jump
Publikováno v:
Cancer Biology & Therapy, Vol 25, Iss 1 (2024)
ABSTRACTEmerging evidence has provided considerable insights into the integral function of reprogramming fatty acid metabolism in the carcinogenesis and progression of endometrial cancer. Linoleic acid, an essential fatty acid with the highest consum
Externí odkaz:
https://doaj.org/article/0a883326542640ba9fd25fa4fea02307
Autor:
Sarah E. Paraghamian, Jianqing Qiu, Gabrielle M. Hawkins, Ziyi Zhao, Wenchuan Sun, Yali Fan, Xin Zhang, Hongyan Suo, Tianran Hao, Varun Vijay Prabhu, Joshua E. Allen, Chunxiao Zhou, Victoria Bae-Jump
Publikováno v:
Cancer Biology & Therapy, Vol 24, Iss 1 (2023)
Poly ADP-ribose polymerase (PARP) inhibitors are effective therapies for cancer patients with homologous recombination (HR) deficient tumors. The imipridone ONC206 is an orally bioavailable dopamine receptor D2 antagonist and mitochondrial protease C
Externí odkaz:
https://doaj.org/article/22955f4a08a9470987b40e5ec77a2a17
Autor:
Miller P. Singleton, Sirisha Thambuluru, Teresa Samulski, Sarah E. Paraghamian, Leslie H. Clark
Publikováno v:
Gynecologic Oncology Reports, Vol 39, Iss , Pp 100912- (2022)
Externí odkaz:
https://doaj.org/article/c03f1162ea6d44d0b8f1823433bb8c76
Publikováno v:
Journal of Minimally Invasive Gynecology. 28:1237-1243
Study Objective Compare survival of patients with advanced epithelial ovarian cancer (EOC) undergoing interval debulking surgery (IDS) with either robot-assisted (R-IDS) or open (O-IDS) approach. Second, we assessed the impact of adjuvant and neoadju
Autor:
Xin Zhang, Jiandong Wang, Yali Fan, Ziyi Zhao, Sarah E. Paraghamian, Gabrielle M. Hawkins, Lindsey Buckingham, Jillian O’Donnell, Tianran Hao, Hongyan Suo, Yajie Yin, Wenchuan Sun, Weimin Kong, Delin Sun, Luyu Zhao, Chunxiao Zhou, Victoria L. Bae-Jump
Publikováno v:
Journal of cancer research and clinical oncology.
Purpose Although paclitaxel is a promising first-line chemotherapeutic drug for ovarian cancer, acquired resistance to paclitaxel is one of the leading causes of treatment failure, limiting its clinical application. Asparagus officinalis has been sho
Autor:
Young Tae Kim, Henrik Falconer, Linnea Ekdahl, Simon Butler-Manuel, Thumuluru Kavitha Madhuri, John F. Boggess, Kyung Jin Eoh, Sarah E. Paraghamian, Jan Persson
Publikováno v:
Gynecologic Oncology. 162:S50-S51
Objectives: We sought to evaluate pregnancy-related outcomes in women who elected to undergo uterine-artery preserving robotic-assisted radical trachelectomy (RRT) for fertility-sparing treatment of early stage cervical cancer. Methods: This is a ret
Autor:
James A. Tulsky, Jessie Ehrisman, Brittany A. Davidson, Sarah E. Paraghamian, Paula S. Lee, Karen Monuszko, Victoria L. Bae-Jump, Angeles Alvarez Secord, Arif H. Kamal, Andrew Berchuck, Yuan Wu
Publikováno v:
Gynecologic Oncology. 162:S169
Objectives: The inclusion of palliative care (PC) across the cancer continuum has been identified as a marker of high-quality cancer care. With limited PC specialists, integrated approaches may be necessary with the primary oncologist providing this
Autor:
Chunxiao Zhou, Varun V. Prabhu, Wenchuan Sun, Sarah E. Paraghamian, Gabrielle Hawkins, Victoria L. Bae-Jump, Joshua E. Allen
Publikováno v:
Gynecologic Oncology. 162:S288
Publikováno v:
Journal of Minimally Invasive Gynecology. 24:1229-1233
Perioperative otorrhagia in association with non-otolaryngologic surgery is rare. The cause is typically attributed to the physiologic derangements associated with the Trendelenburg position and pneumoperitoneum during laparoscopic surgery. The most
Autor:
Y. Zhang, L.K. Drury, Erin K. Crane, A.P. Barr, R.W. Naumann, Leslie H. Clark, Sarah E. Paraghamian, Megan Grant, Jennifer Brown
Publikováno v:
Gynecologic Oncology. 158:e7-e8